This is a preview of subscription content, log in via an institution to check access.
Notes
The research for this study was partly supported by Pfizer.
Reference
Lee BY, et al. Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya. Vaccine : 25 Mar 2019. Available from: URL: http://doi.org/10.1016/j.vaccine.2019.03.007
Rights and permissions
About this article
Cite this article
Measles vaccination of hard-to-reach children in Kenya worthwhile. PharmacoEcon Outcomes News 825, 24 (2019). https://doi.org/10.1007/s40274-019-5790-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5790-0